Monitoring and Rehabilitation for ICIACI Rehabilitation：A Cohort Study

Immune checkpoint inhibitor-associated cardiac injury (ICIACI) is a low-incidence but highly fatal adverse event. A significant knowledge gap exists regarding the disease characteristics and recovery status of patients during the ICIACI convalescent phase. The objectives of this study are to establish a national, multicenter cohort for this patient population and to comprehensively describe their clinical profiles from an integrated Traditional Chinese and Western medicine standpoint, as well as their current rehabilitation status.

NCT Number	NCT07278817
Lead Sponsor	China-Japan Friendship Hospital Collaborators: Weifang Hospital of Traditional Chinese Medicine, Chinese Academy of Medical Sciences, Fuwai Hospital, Second Affiliated Hospital of Nanchang University
Conditions	Immune Checkpoint Inhibitor-Related Myocarditis
Enrollment	340 participants
Start Date	2025-12-30
Primary Completion	2028-07-31 (estimated)
Study Completion	2028-07-31 (estimated)
Updated on ClinicalTrials.gov	2025-12-12